Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO-Reference-Cited by-同舟云学术

Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO

Published:2016-10 Issue: Volume:66 Page:114-124
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Klar M.,Hasenburg A.,Hasanov M.,Hilpert F.,Meier W.,Pfisterer J.,Pujade-Lauraine E.,Herrstedt J.,Reuss A.,du Bois A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5-a population-based study;De Angelis;Lancet Oncol,2013

2. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study;Winter;J Clin Oncol,2007

3. Ovarian cancer: epidemiology, biology, and prognostic factors;Holschneider;Semin Surg Oncol,2000

4. Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies;Xu;J Cancer Res Clin Oncol,2013

5. Age as prognostic factor in premenopausal breast carcinoma;de la Rochefordiere;Lancet,1993

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors in young women with epithelial ovarian cancer: the Young Ovarian Cancer-Care (YOC-Care) study;International Journal of Gynecologic Cancer;2023-12-12

2. Do ethnic chinese older adults with epithelial ovarian cancer survive a poorer prognosis?;Journal of Ovarian Research;2023-06-06

3. Epithelial ovarian cancer in younger age versus older age groups: Survival and clinicopathological features;Journal of Cancer Research and Therapeutics;2023-04-05

4. Ovarian, Uterine, and Vulvovaginal Cancers;Medical Clinics of North America;2023-03

5. LncRNA <i>IDH1-AS1</i> sponges miR-518c-5p to suppress proliferation of epithelial ovarian cancer cell by targeting RMB47;The Journal of Biomedical Research;2023